Tempus AI Inc at Piper Sandler Healthcare Conference Transcript
-- I'm David Westenberg, the life science tools and diagnostics analyst at Piper. With me today is Tempus AI. I'm happy to have the CFO, Jim Rogers. Liz is in the audience as well, if anyone -- any investor here has any questions here.
Questions & Answers
So let's just kick it off with the quarter here. Tempus achieved its first positive adjusted EBITDA in Q3. How do you envision profitability trajectory evolving in '26? And what operating levers will be prioritized to sustain the profitability, but while still -- you got to be a growth company too. So -- ?
Yes. Well, first, I appreciate you having us, David, and everybody for joining. Yes. So achieving adjusted EBITDA positive was kind of a long-term goal for us. We said by the time we were 10, we wanted to kind of achieve that, which we did in Q3. And on a go-forward basis, we don't intend on obviously taking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
